Nov 09, 2021 / NTS GMT
Guillaume Delmas - UBS Group AG - Analyst
Hello, everyone, and welcome to this fireside chat. My name is Guillaume Delmas, I have the European food and HPC team here at UBS. So today, we are absolutely delighted to have with us Tobias Hestler, GSK Consumer Healthcare, Chief Financial Officer.
Tobias, thank you very much for taking the time today to answer our questions. Now, we've got half an hour. So for the purpose of today's fireside chat, I was thinking about starting with a focus on GSK Consumer Healthcare organic sales growth prospects before turning my attention to your margin opportunities.
And with that, let's begin.
Questions and Answers:
Guillaume Delmas - UBS Group AG - AnalystSo on organic sales growth, you anticipate medium-term category growth of 3% to 4% in oral care, 4% to 5% in VMS, 2% to 3% in OTC; which gives broadly a sales weighted average of around 3%. Now you've clearly stated that your ambition is to grow ahead of the market. So maybe can we start by you shedding some light of the main factors that should drive
Trustpilot
